SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
Latest Information Update: 03 Jun 2024
At a glance
- Drugs Clofutriben (Primary)
- Indications Adrenal gland disorders; Cushing syndrome
- Focus Therapeutic Use
- Acronyms ACSPIRE
- Sponsors Sparrow Pharmaceuticals
- 30 May 2024 According to a Sparrow Pharmaceuticals media release, interim data from ongoing clinical trials in patients with ACTH-dependent Cushing's syndrome will be presented by the David Katz during SY55 - Development of Novel Endocrine Therapies by Inhibiting Steroid Biosynthesis session.
- 16 May 2024 Planned number of patients changed from 150 to 30.
- 16 May 2024 Status changed from recruiting to active, no longer recruiting.